معرفی
Kathryn Ball is Chair in Biochemistry and Cell Signalling at the University of Edinburgh's Institute of Genetics and Cancer, where she leads research at the intersection of protein regulation, immune signalling, and disease mechanisms. Her work spans cancer biology, dementia research, and translational biologics development.
- PhD in Biochemistry (University of Leeds)
- Biochemistry Degree (University of Salford)
- Broodbank Fellowship (University of Cambridge)
- Postdoctoral training at Michigan State University and University of Dundee
Her research focuses on proteostasis networks and interferon-regulated proteins like IRF-1, which govern tumour suppression and immune defense. Current projects explore ubiquitin-mediated degradation mechanisms in oesophageal cancer (OAC) and dementia with Lewy bodies (DLB), aiming to develop novel therapeutics through biologics and small molecules.
Key collaborative efforts include partnerships with Dr Tilo Kunath (University of Edinburgh), Professor Ted Hupp (Institute of Genetics and Cancer), and international institutions like Masaryk Memorial Cancer Institute and A* Singapore. Funding sources include the Medical Research Council, Cancer Research UK, and Alzheimer’s Research UK.
- CRUK Senior Cancer Research Fellowship
- Broodbank Fellowship
- Project Grant (CRUK)
The Ball group trains PhD students and researchers in advanced techniques like protein structure-function analysis, synthetic antibody generation, and mass spectrometry-based proteomics while maintaining active clinical and immunological collaborations.
